Has Mike Janicek, MD received payments from drug or device companies?

Yes. Drug and device makers reported $87,730 in general payments to Mike Janicek, MD across 138 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mike Janicek, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mike Janicek, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mike Janicek, MD

Gynecologic Oncology · Scottsdale, AZNPI 1639171754

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (56.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. AstraZeneca accounts for 83.3% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $60,600 and has fallen 98.9% since, to $647 in 2025. Among gynecologic oncology clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$87,730in general payments, 2019–2025

Across 138 payments — averaging $635.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$73K
Clovis Oncology, Inc.$11K
Myriad Genetic Laboratories, Inc.$2K
Intuitive Surgical$599
GSK$350
Merck$292
plus $1K from 11 others

What the payments were for

Consulting fees$27,91832%
Speaking & faculty fees$49,32556%
Travel & lodging$5,5646%
Food & beverage$4,4125%
Education$1000%
Gifts$4120%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	87	$73,079
Clovis Oncology, Inc.	13	$10,526
Myriad Genetic Laboratories, Inc.	3	$1,732
Intuitive Surgical	4	$599
GSK	5	$350
Merck	9	$292
Foundation Medicine, Inc.	2	$170
Galvanize Therapeutics, Inc	1	$152
Genmab U.S., Inc.	2	$147
Baxter Healthcare	2	$139
Stryker	1	$139
On Target Laboratories, Inc	2	$125
Integra Lifesciences Corporation	2	$107
Tempus AI, Inc	1	$82
Eisai Inc.	2	$45
AbbVie	1	$23
Therapeuticsmd, Inc.	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$87,730 in reported general payments places this provider in the 90th percentile of 26 gynecologic oncology providers in Arizona.

See all gynecologic oncology providers in Arizona →

Medicare billing

Part B allowed, 2024

$183,869

Medicare patients

280

Services billed

1,157

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Estradiol	40	$678
Dexamethasone	38	$557
Pantoprazole Sodium	33	$332
Imiquimod	15	$284
Letrozole	14	$282
Prochlorperazine Maleate	30	$268
Ondansetron OdtOndansetron	16	$221
Ondansetron Hcl	25	$159
Tramadol Hcl	65	$146
Ketorolac Tromethamine	11	$117

Paid to pharmacies, not to this prescriber.

Other gynecologic oncology in Scottsdale

Dennis ScribnerScottsdale$76K
Javier MagrinaScottsdale$49K
Arvind BakhruScottsdale$7K
Kristina ButlerScottsdale$646
Paul MagtibayScottsdale$138
Lyndsay WillmottPhoenix$448K
Ivor BenjaminPhoenix$371K
John FarleyPhoenix$43K
Heather DaltonPhoenix$26K
Joseph BuscemaTucson$8K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →